Mike Walker is Vice President, Global Life Sciences Strategy, at Microsoft. Bringing paradigm-shifting digital innovations. getty From therapeutic complexity, FDA regulatory policy changes, geopolitical shocks and an AI race, life sciences supply chain leaders are forced to rewrite their playbook to stay relevant in the era of AI. Since my 2023 market outlook, the conversation has shifted from digital transformation to digital autonomy, whereby networks can sense, decide and act for themselves.